Table 1 Baseline characteristics of 219 patients transplanted in the period of 1998–2008 and surviving at 1 year post HSCT

From: Prognostic significance of liver parameters at 1-year follow-up in children and adults undergoing myeloablative allogeneic stem cell transplantation

  Patients, N (%)
Total 219 (100)
Sex
 Male 126 (58)
 Female 93 (42)
Age (years,mean (range)) 28.1 (0.3–60.3)
Malignant 182 (83)
Non-malignant 37 (17)
Standard risk 98 (45)
High risk 64 (29)
Karnofsky score 90 73 (33)
Karnorsky score >90 143 (65)
Donor type
 Matched sibling donor 119 (54)
 Matched unrelated donor 100 (46)
Stem cell source
 Bone marrow 140 (64)
 Peripheral blood stem 79 (36)
Conditioning regime
 CY + BU 55 (25)
 CY + TBI 111 (51)
 VP16 + TBI 39 (18)
 Other 14 (6)
GvHD prophylaxis
 Cyclosporine 27 (12)
 Methotrexate+cyclosporine 189 (86)
 Other 3 (1)
  1. Abbreviations: BU=busulfan; CY=cyclophosphamide; VP16=etoposide.